LONDON, July 23 (Reuters) - The European Union's drug watchdog cast further doubt on recent studies suggesting a possible cancer risk with Sanofi-Aventis's widely-used Lantus diabetes drug. The ...
Stacker on MSNOpinion
Popular insulin medications and how they are used
SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. U.S. regulators took action Wednesday that ...
(Reuters) - U.S. drugmaker Merck & Co has joined the race to make a cut-price copy of Sanofi's top-selling insulin treatment Lantus, increasing the long-term threat to the French company's $7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback